Celgene Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Celgene are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Celgene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Celgene is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Quick Ratio | 2.66 | |
| Fifty Two Week Low | 89.08 | |
| Target High Price | 116.00 | |
| Fifty Two Week High | 110.70 | |
| Target Low Price | 86.00 |
Celgene |
Celgene Relative Risk vs. Return Landscape
If you would invest (100.00) in Celgene on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Celgene or generate -100.0% return on investment over 90 days. Celgene is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Celgene, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Celgene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celgene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Celgene, and traders can use it to determine the average amount a Celgene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CELG |
Based on monthly moving average Celgene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celgene by adding Celgene to a well-diversified portfolio.
Celgene Fundamentals Growth
Celgene Stock prices reflect investors' perceptions of the future prospects and financial health of Celgene, and Celgene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celgene Stock performance.
| Return On Equity | 1.0E-4 | |||
| Return On Asset | 0.14 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 51.47 % | |||
| Current Valuation | 85.34 B | |||
| Shares Outstanding | 708.74 M | |||
| Price To Earning | 13.31 X | |||
| Price To Book | 7.45 X | |||
| Price To Sales | 4.54 X | |||
| Revenue | 16.35 B | |||
| EBITDA | 8.42 B | |||
| Cash And Equivalents | 9.32 B | |||
| Cash Per Share | 13.15 X | |||
| Total Debt | 20.1 B | |||
| Debt To Equity | 199.90 % | |||
| Book Value Per Share | 9.22 X | |||
| Cash Flow From Operations | 6.35 B | |||
| Earnings Per Share | 7.32 X | |||
| Total Asset | 1.11 B | |||
| Retained Earnings | 21.79 B | |||
| Current Asset | 849.88 M | |||
| Current Liabilities | 141.41 M | |||
Things to note about Celgene performance evaluation
Checking the ongoing alerts about Celgene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celgene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celgene is not yet fully synchronised with the market data | |
| Celgene has some characteristics of a very speculative penny stock | |
| Celgene has a very high chance of going through financial distress in the upcoming years | |
| Celgene has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 78.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Celgene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celgene's stock is overvalued or undervalued compared to its peers.
- Examining Celgene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celgene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celgene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celgene's stock. These opinions can provide insight into Celgene's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Celgene Stock
If you are still planning to invest in Celgene check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celgene's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |